XML 31 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Business Segments and Geographic Information
 6 Months Ended
Apr. 01, 2017
Segment Reporting [Abstract]  
Business Segments and Geographic Information
Business Segments and Geographic Information
The Company has five reportable segments: Diagnostics, Breast Health, GYN Surgical, Skeletal Health and Medical Aesthetics. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, acquisition related fair value adjustments and integration expenses, restructuring, divestiture and facility consolidation charges and other one-time or unusual items.
Identifiable assets for the five principal operating segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its five reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and six months ended April 1, 2017 and March 26, 2016. Segment information is as follows:
 
Three Months Ended
 
Six Months Ended
 
April 1,
2017
 
March 26,
2016
 
April 1,
2017
 
March 26,
2016
Total revenues:
 
 
 
 
 
 
 
Diagnostics
$
296.0

 
$
304.4

 
$
621.3

 
$
615.1

Breast Health
280.5

 
275.8

 
553.8

 
537.9

GYN Surgical
101.1

 
90.9

 
215.9

 
189.7

Skeletal Health
21.8

 
22.2

 
42.8

 
45.7

Medical Aesthetics
16.0

 
—

 
16.0

 
—

 
$
715.4


$
693.3


$
1,449.8


$
1,388.4

Income (loss) from operations:
 
 
 
 
 
 
 
Diagnostics
$
929.7

 
$
34.3

 
$
970.9

 
$
65.8

Breast Health
92.7

 
88.4

 
177.9

 
160.0

GYN Surgical
1.8

 
11.5

 
27.2

 
32.3

Skeletal Health
0.1

 
1.9

 
(5.7
)
 
4.0

Medical Aesthetics
(24.5
)
 
—

 
(24.5
)
 
—

 
$
999.8


$
136.1

 
$
1,145.8

 
$
262.1

Depreciation and amortization:
 
 
 
 
 
 
 
Diagnostics
$
64.4

 
$
83.8

 
$
149.3

 
$
167.4

Breast Health
4.6

 
5.1

 
9.7

 
12.4

GYN Surgical
23.4

 
24.8

 
48.5

 
49.5

Skeletal Health
0.2

 
0.3

 
0.4

 
0.6

Medical Aesthetics
2.5

 
—

 
2.5

 
—

 
$
95.1


$
114.0


$
210.4


$
229.9

Capital expenditures:
 
 
 
 
 
 
 
Diagnostics
$
11.5

 
$
13.0

 
$
21.8

 
$
24.9

Breast Health
1.8

 
3.4

 
4.0

 
5.4

GYN Surgical
3.3

 
3.4

 
7.4

 
6.8

Skeletal Health
0.1

 
0.1

 
0.4

 
0.2

Medical Aesthetics
0.4

 
—

 
0.4

 
—

Corporate
8.0

 
2.1

 
15.8

 
4.4

 
$
25.1


$
22.0


$
49.8


$
41.7

 
 
April 1,
2017
 
September 24,
2016
Identifiable assets:
 
 
 
Diagnostics
$
2,717.7

 
$
3,771.9

Breast Health
813.4

 
809.1

GYN Surgical
1,533.8

 
1,570.7

Skeletal Health
31.4

 
30.9

Medical Aesthetics
1,832.3

 
—

Corporate
1,778.0

 
1,134.4

 
$
8,706.6

 
$
7,317.0


The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended April 1, 2017 and March 26, 2016.
The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from France, Germany and the United Kingdom. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “All others” designation includes Canada, Latin America and the Middle East.
Revenues by geography as a percentage of total revenues were as follows:
 
 
Three Months Ended
 
Six Months Ended
 
April 1,
2017
 
March 26,
2016
 
April 1,
2017
 
March 26,
2016
United States
79.7
%
 
79.0
%
 
78.9
%
 
78.7
%
Europe
9.7
%
 
10.4
%
 
10.1
%
 
10.2
%
Asia-Pacific
6.5
%
 
7.4
%
 
7.4
%
 
7.6
%
All others
4.1
%
 
3.2
%
 
3.6
%
 
3.5
%
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%